Condition: Breast Cancer · Sponsor: The First Affiliated Hospital with Nanjing Medical University
It is a randomized trial to assess the safety and efficacy between hypofractionation radiation and conventional radiation in women who have undergone mastectomy and immediate breast reconstruction. The investigators will evaluate reconstruction complication, radiotherapy side effects, cosmetic and oncologic outcomes.
This description comes directly from the study's public registry record.
Jiangsu Province People's Hospital · 86-025-68307676 · 13770662828@163.com
Always discuss trial participation with your own doctor first.
| Jiangsu Province People's Hospital/The First Affiliated with Nanjing Medical University | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06830083